Biotech | May 05, 2022
Mediso acquires nuclear medicine supplier Bartec Technologies
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
The announcement follows FDA 510(k) clearance of device
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Subscribe To Our Newsletter & Stay Updated
